Less attention has been paid to circulating plasma APOL1 protein, which may be due to several studies that associate kidney allograft failure to donor genotype [12–14] and to a study showing that plasma levels of risk-variant APOL1 did not associate with renal disease [15]. The gene discussed is APOL1; the disease is kidney disorder.